Endocrine Disrupting Chemicals and Male-biased Neurobehavioral Disorders
内分泌干扰化学物质和男性神经行为障碍
基本信息
- 批准号:10561338
- 负责人:
- 金额:$ 37.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-03 至 2027-11-30
- 项目状态:未结题
- 来源:
- 关键词:AdultAndrogen ReceptorAndrogensAnimalsAttentionAttention deficit hyperactivity disorderBasic ScienceBehaviorBehavioralBehavioral AssayBindingBiologicalBirthBrainCentral Nervous SystemChemical ActionsChemical ExposureChildCorpus striatum structureCytosineDNADNA MethylationDNA Modification MethylasesDataDevelopmentDiseaseDoseEconomicsEmbryoEndocrineEndocrine DisruptorsEpidemiologyEpigenetic ProcessEstrogen Receptor alphaEtiologyEventExposure toFemaleFinancial costFutureGenesGenetic ModelsGenomeHealth protectionHeterogeneityHumanImpulsivityIncidenceIndividualInfantInvestigationKnowledgeLinkLongevityMeasurableMeasuresMediatingMethyltransferaseMolecularMouse StrainsMusNeonatalNeurodevelopmental DisorderNeuronsNewborn InfantPathway interactionsPatternPerinatalPhenocopyPhenotypePolychlorinated BiphenylsPublic HealthReportingResearchResearch PersonnelRiskRisk AssessmentRodentRoleSamplingSentinelSeriesSerumSex DifferencesSex DifferentiationSignal TransductionSocial BehaviorSystemTargeted ResearchTechniquesTestingTestosteroneToxic effectTranslatingVentral Striatumautism spectrum disorderbisphenol Acell typecellular targetingdemethylationearly childhoodearly onsetembryonic stem cellexperienceexperimental studygenome-widegenotypic sexhypothalamic pituitary gonadal axisimprintlife time costmalenerve stem cellnervous system developmentneuralneurobehavioral disorderneurotoxicityperfluorooctanoic acidpreferencerepetitive behaviorsexsocialsocial communicationsocial deficits
项目摘要
Children’s neurodevelopmental disorders (NDDs), such as Attention-Deficit/Hyperactivity Disorder (ADHD) and
Autism Spectrum Disorders (ASDs), have tremendous societal, economic, and personal consequences. The
incidence rates and behavioral presentation of these disorders vary by genetic sex, with a male bias. While
multifactorial risks have been reported for this male bias, the mechanistic origins remain unresolved.
Increasingly, epidemiological and animal studies identify a role for endocrine disrupting chemical (EDCs)
exposures in the etiology of children’s NDDs. However, translating risk is difficult because early childhood
exposures are increasingly characterized by low dose exposures to mixtures of EDCs, as exemplified by a
recent study that found 90% of newborn children had measurable serum levels of both bisphenol-a (BPA) and
perfluorooctanoic acid (PFOA) at birth. Our previous data utilizing a curated mixture (MIX) of EDCs,
representative of these infant exposures, found that a low dose EDC mixture altered testosterone (T) levels in
male mice at birth and resulted in male-specific behavioral changes, including reduced attention, impulsivity,
and reduced sociability, phenotypes seen in ADHD and ASDs. Occurring in both rodents and humans, males
experience a surge of T shortly before and after birth that is essential for nervous system development. Our
data indicate that T at birth may be a sensitive target of multiple EDC mixtures. MIX exposure also marginally
reduced DNA methyltransferase (DNMT1) levels and hypomethylated sensitive imprinted genes in male
striatum, a region essential for these behavioral domains. DNA methylation profiles are influenced by various
EDCs and suggested as a potential mechanism by which EDCs confer risk. Consequently, this proposal will
investigate a hypothesized mechanistic pathway linking EDC-induced elevated T levels at birth with DNA
hypomethylation in striatum as a mechanism of sex-dependent behavioral deficits. This hypothesis will be
examined in a series of 3 Aims that systematically manipulate endocrine and epigenetic signals and track brain
and behavioral function into adulthood. First, it will test the ability of neonatal T administration to phenocopy
both the epigenetic and behavioral consequences of MIX EDC exposure. In addition, the role of EDC-induced
DNA hypomethylation via DNMT inhibition will be tested using a genetically modified strain of mice with
reduced DNMT1 activity. Because epigenetic mechanisms of brain development are highly region and cell-type
specific, and our prior assessments used whole striatum, the proposed aims will investigate genome-wide DNA
methylation profiles in neurons from ventral striatum. As an essential step forward, this proposal will integrate
translational behavioral assays and advanced epigenetic techniques to inform our understanding of male
vulnerability. The perinatal T surge is an understudied target of EDC neurotoxicity. The proposed studies will
significantly expand our limited knowledge of how EDC mixtures alter CNS development in a sex-dependent
fashion and will provide new data that are essential for risk assessment and public health protection.
儿童神经发育障碍(NDD),如注意力缺陷/多动障碍(ADHD)和
自闭症谱系障碍(ASD)具有巨大的社会,经济和个人后果。的
这些疾病的发病率和行为表现因遗传性别而异,男性偏好。而
已经报告了这种男性偏倚的多因素风险,但机制性起源仍未得到解决。
越来越多的流行病学和动物研究确定了内分泌干扰物(EDCs)的作用。
暴露在儿童NDD病因中的作用。然而,转换风险是困难的,因为幼儿期
暴露越来越多地以低剂量暴露于内分泌干扰物的混合物为特征,例如
最近的一项研究发现,90%的新生儿血清中的双酚a(BPA)和
全氟辛酸(PFOA)。我们以前的数据利用了一种精心策划的内分泌干扰物混合物(MIX),
这些婴儿暴露的代表,发现低剂量EDC混合物改变了睾丸激素(T)水平,
雄性小鼠在出生时,并导致男性特有的行为变化,包括减少注意力,冲动,
以及社交能力下降,这是多动症和自闭症的表现型。在啮齿动物和人类中,雄性
在出生前后不久经历T激增,这对神经系统发育至关重要。我们
数据表明,出生时的T可能是多种EDC混合物的敏感靶点。MIX曝光率也略有下降
男性中DNA甲基转移酶(DNMT 1)水平降低和低甲基化敏感印迹基因
纹状体,一个对这些行为域至关重要的区域。DNA甲基化谱受多种因素的影响。
内分泌干扰物,并建议作为一个潜在的机制,内分泌干扰物赋予的风险。因此,该提案将
研究一种假设的机制途径,将EDC诱导的出生时T水平升高与DNA
纹状体低甲基化作为性别依赖性行为缺陷机制这一假设将是
在一系列的3个目标中进行了检查,这些目标系统地操纵内分泌和表观遗传信号,
和行为功能进入成年期。首先,它将测试新生儿T给药的能力,
MIX EDC暴露的表观遗传和行为后果。此外,EDC诱导的
通过DNMT抑制的DNA低甲基化将使用具有以下特征的遗传修饰小鼠品系进行测试:
DNMT 1活性降低。因为大脑发育的表观遗传机制是高度区域化和细胞类型化的
具体来说,我们之前的评估使用了整个纹状体,拟议的目标将研究全基因组DNA
来自腹侧纹状体的神经元的甲基化谱。作为向前迈出的重要一步,该提案将纳入
翻译行为分析和先进的表观遗传技术,以告知我们的理解,男性
易损性.围产期T峰是EDC神经毒性的一个研究不足的目标。拟议的研究将
显著扩展了我们对EDC混合物如何改变性别依赖性CNS发育的有限知识,
这将为风险评估和公共卫生保护提供必要的新数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marissa Sobolewski Terry其他文献
Marissa Sobolewski Terry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
电化学纳米适配体传感器对晚期前列腺癌患者外周血中雄激素受体变异体7的灵敏检测
- 批准号:2025JJ60746
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
ac4C 修饰酶 NAT10 通过上调雄激素受体表达
促进前列腺增生进展的机制研究
- 批准号:Q24H050012
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
雄激素受体上调SAA1转录促进肾癌细胞免疫逃避的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
雄激素受体在氧化应激条件下通过维持端粒酶活性
抑制肝癌细胞衰老及其机制研究
- 批准号:2024JJ4095
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
前列腺癌雄激素受体靶向治疗通过转录重编程激活FDX1增强病死亡敏感性的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
雄激素受体调控的RNA m5C修饰促进前列腺癌恩杂鲁胺耐药的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:30.0 万元
- 项目类别:省市级项目
雄激素受体S94磷酸化通过促进配体非依赖核转位介导恩扎卢胺耐药的作用和机制研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
雄激素受体转录抑制circ-SLCO1B7调控TPD52影响肺癌转移的机制研究
- 批准号:2023JJ40968
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
靶向Sub-LBP的新型雄激素受体拮抗剂的发现及其抗前列腺癌活性研究
- 批准号:82304381
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FMNL2介导的雄激素受体磷酸化促进前列腺癌恩扎卢胺耐药的作用及机制研究
- 批准号:82303885
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别: